Inventor · disambiguated record
Georg Fertig
Also filed as: FERTIG GEORG
36 granted patents·17 pending applications·245 citations·filing 1999–2023
97Inventor score
Top patents by PatentIndex Score
53 records- 0195US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0294US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0394US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0494US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0593US9624302B2Nucleic acids encoding antibodies against human CSF-1RHOFFMANN LA ROCHE·Filed 2015·Granted Apr 18, 2017·11 cites·11 claims
- 0693US9617342B2Nucleic acids encoding antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Apr 11, 2017·11 cites·9 claims
- 0793US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 0892US10718762B2Cellular based fret assay for the determination of simultaneous bindingHOFFMANN LA ROCHE·Filed 2018·Granted Jul 21, 2020·5 cites·8 claims
- 0992US9221910B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Dec 29, 2015·20 cites·12 claims
- 1091US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 1191US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 1291US9169323B2Antibodies against human CSF-1RFERTIG GEORG·Filed 2011·Granted Oct 27, 2015·13 cites·15 claims
- 1390US10287352B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2016·Granted May 14, 2019·10 cites·21 claims
- 1490US9988458B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jun 5, 2018·6 cites·14 claims
- 1589US11130810B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·4 cites·36 claims
- 1689US10030073B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Jul 24, 2018·5 cites·23 claims
- 1789US8999327B2Antibodies against human CSF-1R and uses thereofDIMOUDIS NIKOLAOS·Filed 2010·Granted Apr 7, 2015·16 cites·10 claims
- 1888US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 1986US9309319B2Antibodies against human IL33R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Apr 12, 2016·8 cites·7 claims
- 2084US10336830B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·15 claims
- 2183US10023643B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2012·Granted Jul 17, 2018·5 cites·7 claims
- 2283US7208491B2N-monoacylated o-phenylenediaminesHOFFMANN LA ROCHE·Filed 2004·Granted Apr 24, 2007·19 cites·18 claims
- 2383US6790852B22-(2,6-dichlorophenyl)-diarylimidazolesHOFFMANN LA ROCHE·Filed 2003·Granted Sep 14, 2004·19 cites·48 claims
- 2481US7396944B2Thiophene derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Jul 8, 2008·3 cites·19 claims
- 2580US8883159B2Antibodies against CDCP1 for the treatment of cancerBOSSENMAIER BIRGIT·Filed 2010·Granted Nov 11, 2014·4 cites·10 claims
- 2676US2024067749A1Antibodies binding to gprc5dHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2774US2023212308A1Antibodies binding to gprc5dHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2871US7423060B2Thiophene hydroxamic acid derivatives and their use as HDAC inhibitorsHOFFMANN LA ROCHE·Filed 2005·Granted Sep 9, 2008·1 cites·12 claims
- 2971US2019300614A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3070US12391757B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2021·Granted Aug 19, 2025·0 cites·20 claims
- 3165US6946471B22-(2,6-Dichlorophenyl)-DiarylimidazolesHOFFMANN LA ROCHE·Filed 2004·Granted Sep 20, 2005·2 cites·16 claims
- 3264US7759071B2Determination of apoptotic products in tumor patients undergoing therapyROCHE DIAGNOSTICS·Filed 2007·Granted Jul 20, 2010·2 cites·6 claims
- 3364US2009110688A1Combination therapy of type ii anti-cd20 antibody with a proteasome inhibitorFERTIG GEORG·Filed 2008·Application pending·0 cites
- 3464US2015080556A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 3564US2021054094A1Antibodies binding to gprc5dHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3662US2016000912A1Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitorROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 3759US2022411491A1Antibodies binding to gprc5dHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3859US2005118169A1Antibodies against interleukin-1 receptor and uses thereofFiled 2004·Application pending·0 cites
- 3957US2009191187A1Antibodies against interleukin-1 receptor and uses thereofBARTKE ILSE·Filed 2009·Application pending·0 cites
- 4056US2012219549A1Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitorFERTIG GEORG·Filed 2012·Application pending·0 cites
- 4155US7173060B2Oxime derivatives and their use as pharmaceutically active agentsHOFFMANN LA ROCHE·Filed 2004·Granted Feb 6, 2007·0 cites·12 claims
- 4255US2022259318A1Antibodies binding to gprc5dHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 4354US7501451B2Mono-acylated o-phenylendiamines derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Mar 10, 2009·0 cites·31 claims
- 4454US2011200598A1Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitorHOFFMANN LA ROCHE·Filed 2011·Application pending·0 cites
- 4553US8785153B2Antibodies against human IL33R and uses thereofFERTIG GEORG·Filed 2012·Granted Jul 22, 2014·0 cites·16 claims
- 4653US2017275368A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 4752US7071219B2Mono-acylated o-phenylendiamines derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Jul 4, 2006·0 cites·39 claims
- 4850US7638553B2Hydroxamates, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Dec 29, 2009·0 cites·20 claims
- 4948US2003219841A1Method and reagent for the detection of apoptotic cells and of a protease activated during apoptosisFiled 2002·Application pending·0 cites
- 5046US7098247B2Arylene-carboxylic acid (2-amino-phenyl)-amide derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 29, 2006·0 cites·37 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Georg Fertig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →